CardioVascMMM
@cardiovascmmm.bsky.social
Vascular and cardiac medicine
Phd
Sports
Phd
Sports
Well is that the terrorisms trump was talking about before
June 6, 2025 at 3:34 PM
Well is that the terrorisms trump was talking about before
But PAD outcomes are missing in all 4 trials that would be great additional information….
May 14, 2025 at 3:22 AM
But PAD outcomes are missing in all 4 trials that would be great additional information….
I am always wondering why pad events are not included in the outcomes….
May 12, 2025 at 12:55 PM
I am always wondering why pad events are not included in the outcomes….
Hat sich meines Wissens nach auch noch nie eine aufgestellt, woher soll sie dann kommen? Ist also nen Quatsch Post der ihnen Glaubwürdigkeit nimmt, auch wenn die weibliche Representation in Führungspositionen ein unendlich wichtiges Thema ist.
April 26, 2025 at 6:35 AM
Hat sich meines Wissens nach auch noch nie eine aufgestellt, woher soll sie dann kommen? Ist also nen Quatsch Post der ihnen Glaubwürdigkeit nimmt, auch wenn die weibliche Representation in Führungspositionen ein unendlich wichtiges Thema ist.
Well, so true. But both randomized trials trials are focused on shock patients and have a neutral outcome. We all know that observational data is delicate due to serveral biases. Look at our Cardiac arrest study. academic.oup.com/eurheartj/ar...
Coronary angiography after cardiac arrest without ST-elevation myocardial infarction: a network meta-analysis
AbstractAims. This network meta-analysis aimed to assess the effect of early coronary angiography (CAG) compared with selective CAG (late and no CAG) for p
academic.oup.com
April 1, 2025 at 4:32 AM
Well, so true. But both randomized trials trials are focused on shock patients and have a neutral outcome. We all know that observational data is delicate due to serveral biases. Look at our Cardiac arrest study. academic.oup.com/eurheartj/ar...
After the shock trial this one is also negative. Why should we consider using the iabp?
March 31, 2025 at 10:53 AM
After the shock trial this one is also negative. Why should we consider using the iabp?
Thats what we founf in our meta-analysis as well. But apixaban had less bleeding events and was as effective.
For sure lower quality data. link.springer.com/article/10.1...
For sure lower quality data. link.springer.com/article/10.1...
Oral anticoagulation in patients with left ventricular thrombus: a systematic review and network meta-analysis with reconstructed time-to-event data - Clinical Research in Cardiology
Background Left ventricular thrombus (LVT) is associated with high rates of systemic embolism. Vitamin K antagonists (VKAs) are the only approved treatment for LVT. Although evidence suggests direct o...
link.springer.com
March 30, 2025 at 9:51 AM
Thats what we founf in our meta-analysis as well. But apixaban had less bleeding events and was as effective.
For sure lower quality data. link.springer.com/article/10.1...
For sure lower quality data. link.springer.com/article/10.1...
Interesting! Did you change any habits after you read the results of this study?
March 30, 2025 at 9:48 AM
Interesting! Did you change any habits after you read the results of this study?
What can we take away from it for our daily practice?
March 30, 2025 at 9:43 AM
What can we take away from it for our daily practice?
What do you think is the reason for the missing money in the NHS? Where is the money going? Or are the people not willing to pay for healthcare?
March 29, 2025 at 6:43 PM
What do you think is the reason for the missing money in the NHS? Where is the money going? Or are the people not willing to pay for healthcare?
Great. We need a study comaparing finerenone to spironolacton
March 29, 2025 at 5:31 PM
Great. We need a study comaparing finerenone to spironolacton
That’s huge! A reduction in MALE is exactly what we need for these patients, given their significant disease burden.
March 29, 2025 at 4:09 PM
That’s huge! A reduction in MALE is exactly what we need for these patients, given their significant disease burden.
Super interesting and highly relevant! I’m particularly curious about the subgroups—are there differences in the risk of recurrent events depending on the type of cancer?
March 29, 2025 at 4:05 PM
Super interesting and highly relevant! I’m particularly curious about the subgroups—are there differences in the risk of recurrent events depending on the type of cancer?
Super interesting and highly relevant! I’m particularly curious about the subgroups—are there differences in the risk of recurrent dvt events depending on the type of cancer?
March 29, 2025 at 4:05 PM
Super interesting and highly relevant! I’m particularly curious about the subgroups—are there differences in the risk of recurrent dvt events depending on the type of cancer?